RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE

      The quick sepsis-related organ failure score has limited value for predicting adverse outcomes in sepsis patients with liver cirrhosis

      한글로보기

      https://www.riss.kr/link?id=A106931004

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background/Aims: The quick Sepsis-related Organ Failure Assessment (qSOFA) is a newly developed risk stratification tool, which has been presented along with a new sepsis definition, to classify infected patients outside of the intensive care unit (IC...

      Background/Aims: The quick Sepsis-related Organ Failure Assessment (qSOFA) is a newly developed risk stratification tool, which has been presented along with a new sepsis definition, to classify infected patients outside of the intensive care unit (ICU). We evaluated the clinical usefulness of qSOFA for predicting adverse outcomes in sepsis patients with liver cirrhosis.
      Methods: We performed a retrospective cohort study to assess the utility of qSOFA in sepsis patients with liver cirrhosis for whom medical emergency teams (METs) were activated in general wards at an academic tertiary care hospital between March 2008 and December 2015. qSOFA, Systemic inflammatory response syndrome (SIRS), modified early warning score (MEWS), and sequential (sepsis- related) organ failure assessment (SOFA) scores were calculated according to data at MET activation.
      Results: Of 188 patients, 69 (36.7%) had a qSOFA score of 0 or 1 point and 119 (63.3%) had ≥ 2 points. The areas under the receiver operating characteristic curve (AUROC) for ICU transfer on the SOFA (AUROC, 0.691; 95% confidence interval [CI], 0.615 to 0.767) or MEWS (AUROC, 0.663; 95% CI, 0.586 to 0.739) were significantly higher compared to those for qSOFA (AUROC, 0.589; 95% CI, 0.507 to 0.671) or SIRS (AUROC, 0.533; 95% CI, 0.451 to 0.616).
      Conclusions: Our findings suggest that qSOFA score may have limited utility in predicting adverse outcomes in sepsis patients with liver cirrhosis at MET activation.
      Either MEWS or another screening tool is needed for detecting early sepsis in these patients.

      더보기

      참고문헌 (Reference)

      1 Subbe CP, "Validation of a modified early warning score in medical admissions" 94 : 521-526, 2001

      2 Rhodes A, "The surviving sepsis campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study)" 41 : 1620-1628, 2015

      3 Merion RM, "The survival benefit of liver transplantation" 5 : 307-313, 2005

      4 Vincent JL, "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine" 22 : 707-710, 1996

      5 Williams JM, "Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection" 151 : 586-596, 2017

      6 Rhodes A, "Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. 2016" 43 : 304-377, 2017

      7 Levy MM, "Surviving sepsis campaign : association between performance metrics and outcomes in a 7. 5-year study" 40 : 1623-1633, 2014

      8 Bajaj JS, "Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience" 56 : 2328-2335, 2012

      9 Innocenti F, "SOFA score in septic patients : incremental prognostic value over age, comorbidities, and parameters of sepsis severity" 13 : 405-412, 2019

      10 Bruns T, "Risk factors and outcome of bacterial infections in cirrhosis" 20 : 2542-2554, 2014

      1 Subbe CP, "Validation of a modified early warning score in medical admissions" 94 : 521-526, 2001

      2 Rhodes A, "The surviving sepsis campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study)" 41 : 1620-1628, 2015

      3 Merion RM, "The survival benefit of liver transplantation" 5 : 307-313, 2005

      4 Vincent JL, "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine" 22 : 707-710, 1996

      5 Williams JM, "Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection" 151 : 586-596, 2017

      6 Rhodes A, "Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. 2016" 43 : 304-377, 2017

      7 Levy MM, "Surviving sepsis campaign : association between performance metrics and outcomes in a 7. 5-year study" 40 : 1623-1633, 2014

      8 Bajaj JS, "Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience" 56 : 2328-2335, 2012

      9 Innocenti F, "SOFA score in septic patients : incremental prognostic value over age, comorbidities, and parameters of sepsis severity" 13 : 405-412, 2019

      10 Bruns T, "Risk factors and outcome of bacterial infections in cirrhosis" 20 : 2542-2554, 2014

      11 Churpek MM, "Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit" 195 : 906-911, 2017

      12 Raith EP, "Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit" 317 : 290-300, 2017

      13 Thabut D, "Model for endstage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure" 46 : 1872-1882, 2007

      14 Galbois A, "Improved prognosis of septic shock in patients with cirrhosis : a multicenter study" 42 : 1666-1675, 2014

      15 Shankar-Hari M, "Developing a new definition and assessing new clinical criteria for septic shock : for the third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)" 315 : 775-787, 2016

      16 Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine" 101 : 1644-1655, 1992

      17 Jalan R, "Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013" 60 : 1310-1324, 2014

      18 Fernandez J, "Bacterial infections in cirrhosis : epidemiological changes with invasive procedures and norfloxacin prophylaxis" 35 : 140-148, 2002

      19 Seymour CW, "Assessment of clinical criteria for sepsis: for the third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)" 315 : 762-774, 2016

      20 Donnelly JP, "Application of the Third International Consensus Definitions for Sepsis(Sepsis-3)Classification : a retrospective population-based cohort study" 17 : 661-670, 2017

      21 Levy MM, "2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference" 29 : 530-538, 2003

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.37 0.26 1.02
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.73 0.566 0.13
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼